Health Impacts of Ultrafine Particles (UFPs)

Ultrafine particles (UFPs) are omnipresent in the air we breathe, originating from various sources such as human activities (like transportation and cooking) and natural environmental processes. Given their ubiquity, one might assume they pose no significant threat to human health.

However, history has shown that substances once considered harmless can have serious health implications. This has been the case with many environmental pollutants, including lead, PM10, and PM2.5. A growing body of research is now revealing the health impacts of UFPs, suggesting that they pose a unique health hazard. Monitoring UFPs could be crucial in addressing health concerns related to particulate air pollution.

Health Effects of Particulates in Ambient Air

The adverse health effects of outdoor air pollution are not only due to harmful gases but also to tiny particles that can lodge deep within the lungs. Extensive research has been conducted on the health effects of airborne particulate matter (PM) of 2.5 micrometers or less (PM2.5).

It is well-established that exposure to ambient PM2.5 is linked to respiratory illnesses like chronic bronchitis and pneumonia, as well as cardiovascular diseases such as congestive heart failure and coronary heart disease.^1,2 Monitoring PM2.5 is vital, as over 90% of the monetized social costs of particulate air pollution are attributed to particles 2.5 micrometers and smaller.³ 

Since UFPs are smaller than 2.5 micrometers, they are technically included in the PM2.5 metric. However, due to their tiny size and low mass, a large population of UFPs can be present without significantly affecting PM2.5 mass measurements. This makes it challenging to isolate the health effects of UFPs from those of PM2.5. Despite this, studies specifically designed to examine UFP exposure are building a case that UFPs pose a greater health hazard than previously assumed.

Health Effects of Ultrafine Particles

UFPs, also known as nanoparticles, are particles 0.1 microns in size or smaller. The smallest UFPs are only 5-10 atoms across. Due to their small size, UFPs behave differently within the respiratory system compared to larger particles. One significant characteristic of UFPs is their ability to cross the blood-brain barrier.⁴

Researchers have utilized this ability to demonstrate the consequences of UFP exposure. For instance, a 2020 study published in Nature Communications found nanoparticles formed outside the human body in human lung fluid.⁵  The exposure occurred as individuals carried out routine activities, encountering these particles in the surrounding air, which were then absorbed and accumulated in their lung fluid.

In another study, volunteers inhaled aerosolized gold nanoparticles of sizes 5 and 30 nm. These particles were detected in the volunteers' blood and urine within 24 hours and remained present after three months.⁶ This suggests that UFPs can easily enter the body and persist for extended periods, potentially causing long-term health effects.

Other research has focused on understanding the pathways between PM0.1 exposure and health consequences. Disease development can occur via oxidative stress, epigenetic changes, and other mechanistic pathways, all initiated by exposure to UFPs. Oxidative stress can cause inflammation and cell damage, leading to health problems such as cardiovascular disease and cancer. Epigenetic changes can alter gene expression, affecting cell behavior and disease development.⁷

Monitoring Ultrafine Particles to Address Health Concerns

The scientific consensus that UFPs pose a unique health hazard is growing stronger. Since the primary goal of ambient air quality monitoring is to protect public health, incorporating UFP measurements into regular monitoring efforts could help identify areas with high UFP concentrations and prompt protective measures. Efforts are already underway in the ACTRIS network and other research initiatives. Standardizing UFP measurement techniques, as outlined in European technical specifications EN 16976* and CEN/TS 17434, will strengthen epidemiological studies on UFP effects.

*EN 16976 is formerly known as the Technical Specification CEN/TS 16976, and established by the European Committee for Standardization (CEN).

Complete Air Quality Monitoring Solution from a Single Supplier